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Abstract
Background: Cell-to-cell HIV transmission requires cellular contacts that may be in part mediated
by the integrin leukocyte function antigen (LFA)-1 and its ligands intercellular adhesion molecule
(ICAM)-1, -2 and -3. The role of these molecules in free virus infection of CD4 T cells or in
transinfection mediated by dendritic cells (DC) has been previously described. Here, we evaluate
their role in viral transmission between different HIV producing cells and primary CD4 T cells.
Results: The formation of cellular conjugates and subsequent HIV transmission between
productively infected MOLT cell lines and primary CD4 T cells was not inhibited by a panel of
blocking antibodies against ICAM-1, ICAM-3 and α and β chains of LFA-1. Complete abrogation of
HIV transmission and formation of cellular conjugates was only observed when gp120/CD4
interactions were blocked. The dispensable role of LFA-1 in HIV transmission was confirmed using
non-lymphoid 293T cells, lacking the expression of adhesion molecules, as HIV producing cells.
Moreover, HIV transmission between infected and uninfected primary CD4 T cells was abrogated
by inhibitors of gp120 binding to CD4 but was not inhibited by blocking LFA-1 binding to ICAM-1
or ICAM-3. Rather, LFA-1 and ICAM-3 mAbs enhanced HIV transfer. All HIV producing cells
(including 293T cells) transferred HIV particles more efficiently to memory than to naive CD4 T
cells.
Conclusion: In contrast to other mechanisms of viral spread, HIV transmission between infected
and uninfected T cells efficiently occurs in the absence of adhesion molecules. Thus, gp120/CD4
interactions are the main driving force of the formation of cellular contacts between infected and
uninfected CD4 T cells whereby HIV transmission occurs.
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Cell-to-cell HIV transmission is a major determinant of
HIV spread in vivo [1] and is required for efficient HIV rep-
lication in vitro [2]. Although free HIV particles are infec-
tious, they show a short lifespan at 37°C [3] and lower
infectivity than cell-to-cell HIV transmission [4]. Cell-to-
cell virus transmission occurs through the formation of
stable cellular contacts defined as virological synapses [5],
that can be formed between a target CD4 T cell and either
a dendritic cell (DC) or a productively HIV infected cell.
Although both synapses share the common function of
transmitting HIV to CD4 T cells, their structures apprecia-
bly differ: DC-T cell synapses concentrate TCR/MHC com-
plexes in the central supramolecular activation cluster
(cSMAC), while in T cell-T cell synapses the cSMAC is
formed by the binding of HIV envelope glycoprotein
(Env) to CD4 [5,6].
LFA-1 appears to play a key role in the formation of viro-
logical synapses by interacting with its high-affinity ligand
CD54/ICAM-1 [7-9]. The binding of ICAM-1 to LFA-1 is
facilitated by initial low-affinity interactions of LFA-1 with
the widely expressed ligand CD50/ICAM-3 at the cSMAC
[10,11] that leads to LFA-1 activation and clustering in the
periphery of the synaptic structures (peripheral supramo-
lecular activation cluster or pSMAC) stabilizing cellular
contacts and providing costimulatory signals [8,12].
However, recent work suggests that the cSMAC of immu-
nological synapses may be built in the absence of LFA-1
[12].
The active contribution of LFA-1/ICAM-1 interaction to
HIV spread has been described during free virus infection
of CD4 T cells and infection mediated by DC. In both
cases, LFA-1 increases viral infectivity [9,13] and directs
infection towards CD45RO+ memory CD4 T cells [14,15].
However, the involvement of adhesion molecules in the
transmission of HIV between infected and uninfected
CD4 T cells is poorly defined: although LFA-1 may modu-
late the formation of cellular conjugates and synaptic
structures, a clear correlation between LFA-1 expression
and HIV transmission has not been described [8].
Cellular contacts between infected and uninfected pri-
mary CD4 T cells lead to the polarization of cell-surface
Env expression and viral budding [5,6,16] towards the
contact area. Concomitant polarization of CD4 results in
the formation of a virological synapse [17]. This synaptic
structure allows high levels of viral transfer between
infected and target cells [18,19] which, aside from increas-
ing viral entry, also activates endocytic mechanisms of
HIV capture that require the extracellular but no the intra-
cellular moiety of CD4 [18].
To define the contribution of adhesion molecules to the
process of HIV transfer between infected and uninfected
CD4 T cells, we have cultured primary CD4 T cells with
different productively infected cell lines or primary cells.
Our data suggest that, in contrast to other mechanisms of
HIV spread, the interaction of LFA-1 with its main ligand
ICAM-1 is dispensable for HIV transmission between CD4
T cells.
Results
The role of adhesion molecules in cell-to-cell contacts 
between HIV infected and uninfected T cells
The known role of LFA-1 in HIV attachment [13] and for-
mation of synaptic structures [5] led us to evaluate the role
of adhesion molecules in our previously described model
of T cell-to-T cell HIV transmission [18]. First, we con-
firmed the expression of LFA-1 (total and activated
forms), ICAM-1 and -3 in target purified primary CD4 T
cells and effector MOLT cells. All cells stained positive for
these antigens with different intensities. Primary CD4 T
cells expressed high levels of LFA-1 and lower levels of
ICAM-3, ICAM-1 and activated LFA-1. Memory cells
showed higher expression of all antigens compared to
naive cells (Figure 1). All MOLT cells (uninfected and
infected with either NL4-3 or BaL viruses) expressed lower
levels of LFA-1 (total and activated forms) than primary
CD4 T cells, while ICAM-1 and ICAM-3 expression was
comparable to that of naive CD4 T cells (Figure 1). The
expression of CD4 and HIV Env was also evaluated. Cell
surface CD4 staining served to confirm similar levels of
expression in naive and memory primary cells, and the
complete downregulation in productively infected cells
(Figure 1). Env expression was comparable in both NL4-3
and BaL infected MOLT cells.
Since the potential effect of adhesion molecules on HIV
transmission is expected to be associated with the initial
steps of cellular contacts, we have developed a flow
cytometry method to quantify cellular conjugates formed
between MOLT and fluorescently-labeled CD4T cells. In
these experiments, individual cells could be identified by
forward scatter and fluorescence values. Cellular conju-
gates displayed high levels of fluorescence (given by the
labeled CD4 T cells) and forward scatter values similar to
the MOLT cell population (Figure 2A). We employed
uninfected MOLT cells as control and also analyzed the
effects of different inhibitors. MOLT NL4-3 and BaL cells
showed higher percentage of cellular conjugates (13%
and 8% respectively) than uninfected cells (1%) (Figure
2A, Control). Regardless of viral tropism, cellular conju-
gates were significantly (p < 0.05) inhibited by the anti-
CD4 mAb Leu3a or by continuous shacking during incu-
bation as described by Sourisseau et al [2] (Fig 2A). In
contrast, the addition of antagonists of either CXCR4
(AMD3100) or CCR5 (TAK779) and the gp41 inhibitorPage 2 of 13
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cell fusion) failed to inhibit the formation of cellular con-
jugates (Figure 2B). Similarly, the addition of blocking
antibodies against adhesion molecules (LFA-1, ICAM-1
and -3), did not show any significant impact on the for-
mation of cellular conjugates. As a whole, these data sug-
gest that the expression of HIV Env and CD4 are the main
determinants of the formation of cellular conjugates
between infected and uninfected CD4 T cells.
The role of adhesion molecules in HIV transfer between 
CD4 T cells
Recently, Jolly et al [8] have suggested that during HIV
transmission between CD4 T cells, adhesion molecules
may modulate not only the formation of cellular conju-
gates but also the function of virological synapses [8]. To
address this possibility in our culture system, we tested the
effect of antibodies blocking adhesion molecules in an
assay that measures transfer of HIV particles from infected
to uninfected T cells. The blockade of the α or β chains of
LFA-1 (CD11a and CD18, respectively), the activated
form of LFA-1, and ICAM-1 or ICAM-3 did not show any
inhibitory effect on the transfer of HIV particles, measured
as the percentage of p24 positive target cells (Figure 3).
Similarly, combinations of anti-ICAM-1 with either anti-
ICAM-3 or anti-LFA-1 antibodies failed to block HIV
transfer (data not shown). In the search of other adhesion
components expressed on the cell surface, which could be
involved in the formation of cellular conjugates or HIV
attachment, we have also evaluated the role of CD147 and
CD29 [20,21]. Blocking antibodies against these mole-
cules did not inhibit HIV transfer; rather a significant
The expression of adhesion molecules in effector and targets cellsFigure 1
The expression of adhesion molecules in effector and targets cells. Primary CD4 T cells as well as MOLT cells unin-
fected or chronically infected with NL4-3 or BaL isolates were analyzed for the expression of ICAM-1, ICAM-3, total LFA-1, 
the activated form of LFA-1 and CD4. Staining of the cell surface molecules was performed using monoclonal antibodies 
RM3A5, 140.11, R7.1, mAb24 and Leu3a respectively. The expression of HIV Env was evaluated in MOLT cells using pooled 
serums from HIV infected individuals. Figure shows the expression of each individual antigen (empty peaks) with the negative 
control of staining (solid peaks). Histograms show a single representative experiment.
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Formation of T cell-T cell conjugatesigure 2
Formation of T cell-T cell conjugates. Panel A shows a representative experiment of quantification of cellular contacts between MOLT cells and puri-
fied CMRA-labeled CD4 T cells. MOLT cells appear as an unstained population with high forward scatter values (in orange); while CD4 T cells were iden-
tified by fluorescent staining and low forward scatter values (in purple). Events displaying bright fluorescence and forward scatter values consistent with 
MOLT cells were defined as cellular conjugates (in red, gate MOLT-CD4 in the figure). The percentage of CD4 T cells forming conjugates in the absence 
or the presence of Leu3a, or under continuous shacking condition is shown in each plot. Panel B shows the quantification of cellular conjugates in the pres-
ence of the following inhibitors: mAbs against the adhesion molecules ICAM-1 (RM3A5), ICAM-3 (140.11) and LFA-1 (R7.1), coreceptor antagonists 
AMD3100 and TAK779 (all at 10 μg/ml), gp41 inhibitor C34 (1 μg/ml) or Leu3a (5 μg/ml). Data are Mean ± SD of 3 independent experiments including 
cells from 3 different donors. Asterisks indicate a significant inhibition in the formation of conjugates in the presence of Leu3a and under shaking condi-
tions.
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Retrovirology 2008, 5:32 http://www.retrovirology.com/content/5/1/32increase was observed in the presence of the anti-CD147
antibody (Figure 3).
The failure of antibodies against adhesion molecules to
inhibit the formation of cellular conjugates and the block-
ing effect of Leu3a suggested that gp120 binding to CD4
is the main driving force of the formation of T cell-to-T cell
virological synapses. Therefore, T cell-to-T cell HIV trans-
mission might take place in the absence of LFA-1 interac-
tions with ICAMs. To investigate the requirements of LFA-
1 function in HIV transmission, we used 293T cells. First,
we confirmed that these cells do not show detectable
expression of LFA-1, ICAM-1, -2 and -3 on their surface
(Figure 4A). Second, we transfected 293T cells with plas-
mids coding for an env deficient genome of HIV (Δenv)
together with an env/rev cassette (NL4-3 isolate). Of note,
293T cells transfected with the plasmid Δenv alone were
used as a control of potential Env-independent nonspe-
cific transmission. Transfected cells were then cocultured
with primary CD4 T cells to analyze cell-to-cell viral trans-
fer. HIV was specifically transferred from Env-expressing
293T to CD4 T cells by a mechanism similar to that
observed for MOLT infected cells: it was abrogated by
Leu3a and unaffected by the addition of C34 (Figure 4B),
reasserting that the binding of LFA-1 to its ligands is not
necessary to observe an efficient HIV transmission.
Selectivity of LFA-1 independent HIV transfer
Since the expression of adhesion molecules in memory
cells is higher compared to the naïve subset (Figure 1), the
The role of adhesion molecules on T cell-to-T cell HIV transmissionFigu e 3
The role of adhesion molecules on T cell-to-T cell HIV transmission. Blocking antibodies against the indicated cell 
surface molecules were used to inhibit the transfer of HIV particles after 2 h of coculture of primary CD4 T cells with unin-
fected MOLT (white bars), MOLT NL4-3 (grey bars) or MOLT BaL cells (dark bars). Concentrations were 10 μg/mL for all 
mAbs against cell surface molecules, except for Leu3a (5 μg/mL) and C34 (1 μg/mL). Data are Mean ± SD of 3 independent 
experiments employing cells of 3 different donors. Asterisks indicate a significant inhibition in HIV transmission in the presence 
of Leu3a.
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LFA-1 independent cell-to-cell HIV transmissionFigure 4
LFA-1 independent cell-to-cell HIV transmission. Panel A depicts the expression of the indicated adhesion molecules on 
the surface of the 293T cell line. The percentage of positive cells is indicated in each histogram. Control histogram corre-
sponds to background of staining. Panel B shows HIV transfer from 293T cells, transfected to produce HIV particles, to target 
CD4 T cells in the absence (light bars) or presence (grey bars) of NL4-3 Env expression. The effect on the addition of blocking 
antibodies against CD4 (Leu3a) and the gp41 inhibitory peptide C34 was also tested. Data (Mean ± SD) were obtained using 
cells from 3 different donors. Asterisk indicates a significant inhibition in HIV transmission in the presence of Leu3a within 
NL4-3 Env transfected 293T cells.
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Retrovirology 2008, 5:32 http://www.retrovirology.com/content/5/1/32active contribution of LFA-1 to the process of HIV spread
has been associated to the higher susceptibility of CD4
CD45RO T cells to HIV attachment and infection [14].
Therefore, we sough to evaluate whether LFA-1-independ-
ent HIV transfer between CD4 T cells might present a dif-
ferent target cell selectivity. In this set of experiments, after
coculture with HIV producing cells, we gated memory
(CD45RO+) and naïve (CD45RO-) cells and then we cal-
culated the percentage of p24 positive cells in each subset.
Figure 5A (left) shows that memory CD4 T cells had sig-
nificantly higher levels of p24 than naive cells when coc-
ultured with both NL4-3 and BaL chronically infected
MOLT cells (p < 0.05). This selectivity of HIV transfer
towards the memory subset was independent of LFA-1
binding to ICAM-1, as it was not modified by the addition
of the anti-ICAM-1 mAb RM3A5 (Fig 5A, right).
Since 293T cells have been used as a standard model to
evaluate the role of ICAM-1 in HIV infection [13,14], we
cotransfected these cells with a plasmid coding for ICAM-
1. The expression of HIV Env and ICAM-1 was assessed by
flow cytometry, being ICAM-1 expressed with more effi-
ciency (26 ± 6% ICAM-1 expressing cells vs. 14 ± 3% Env
expressing cells, with relative fluorescence intensity (RFI)
values of 4.3 ± 2.3 and 2.1 ± 0.4, respectively, Figure 5B).
The selective transfer to memory cells was still observed in
the absence of adhesion molecules by using 293T cells
transfected as in Figure 4. Once more, memory T cells
showed significant higher values of p24 content than
naïve cells (Figure 5C, left). High levels of ICAM-1 expres-
sion in effector cells significantly increased the efficiency
of HIV transmission to both naïve (1.2 fold) and memory
T cells (2.1 fold) (Figure 5C, left). HIV transfer mediated
by ICAM-1 expressing 293T cells was not modified by
C34, and was inhibited by Leu3a (data not shown). Con-
sistent with a specific role of ICAM-1 in this cellular
model, the anti-ICAM-1 mAb RM3A5 reverted the net
increase of HIV transfer and the higher selectivity towards
memory cells induced by ICAM-1 expression. However,
this antibody was unable to completely block HIV transfer
(Figure 5C, right). These data support the idea that the
role of ICAM-1 is cell type dependent and provide a posi-
tive control for the inhibitory effect of the anti-ICAM-1
mAb RM3A5.
HIV transmission between primary CD4 T cells
The different role of ICAM-1 observed in HIV transfer
from MOLT or from 293T cells to CD4 T cells could be
due to a different balance between the expression of
ICAM-1 and HIV Env on the surface of these cells. In fact,
293T cells expressed lower levels of Env than ICAM-1 both
in terms of percentage of positive cells and RFI (Figure
5B). In contrast, the expression of ICAM-1 is low in MOLT
cells, which in turn express higher levels of HIV Env (RFI
values of 2.65 and 6.95 for ICAM-1 and Env, respectively
in MOLT NL4-3 infected cells, Figure 1). To clearly define
the role of ICAM-1 in HIV transmission between primary
CD4 T cells, we purified productively infected CD4 T cells
from infected cultures of peripheral blood mononuclear
cells (PBMC) and used them as effector cells. First, we
determined the expression of LFA-1 (mAb R7.1), ICAM-1
(mAb RM3A5) and ICAM-3 (mAb 140.11) in gated
CD3+CD8-CD4- T cells of infected PBMC cultures, which
represent the productively infected cell population [18].
The expression of these molecules was compared to the
CD3+CD8-CD4+ cells of the same cultures, finding no
significant differences (Figure 6A). Interestingly, the
expression of ICAM-1 and LFA-1 was higher than in
MOLT cells (Figure 1). Next, we purified productively
infected CD3+/CD8-/CD4- T cells that were cocultured
with unstimulated uninfected CD4 T cells. Transfer of HIV
was again detected in both naïve and memory subsets,
being significantly (p < 0.05) higher in the latter subset
and significantly (p < 0.05) inhibited by Leu3A but not
C34 (Figure 6B). Similarly to MOLT cells, the addition of
blocking ICAM-1, LFA-1 or ICAM-3 antibodies did not
inhibit HIV transfer; rather significant increases were
induced by the 140.11 anti-ICAM-3 or the R7.1 anti-LFA-
1 antibodies (Figure 6B). To address the role of antibody
mediated cross linking and signaling on these enhancing
effects, we compared the effect of Fab fragments of the
ICAM-3 mAb 140.11 or a monomeric soluble form of
ICAM-1 with the effect of whole IgGs. The increase in HIV
transfer induced by anti-LFA-1 R7.1 IgG was significantly
lost when LFA-1 was blocked using sICAM-1 (Figure 6B).
Similarly, significant differences were observed between
the enhancing effect of the anti-ICAM-3 140.11 IgG and
its Fab fragment, although the latter still retained some
ability to increase HIV transfer (Figure 6B). None of the
inhibitors used, unless the anti-CD4 mAb Leu3a, inhib-
ited HIV transfer. In summary, these data support the idea
that the binding of HIV Env (gp120) to CD4 governs HIV
transfer between CD4 T cells in the absence of LFA-1 inter-
actions with ICAM-1 or -3. Nevertheless, signaling
through these adhesion molecules may modulate both
the extent and the target cell selectivity of viral transfer.
Discussion
We provide several lines of evidence that highlight the rel-
evance of gp120 binding to CD4 as a primary determinant
in the formation of T cell-T cell conjugates over the role of
HIV coreceptors CXCR4 and CCR5 or the adhesion mole-
cules studied here. Concerning coreceptors, it is well
known that CXCR4 is highly expressed in cultured pri-
mary T cells, while CCR5 is restricted to a subset of mem-
ory cells [22]. Therefore, a potential active participation of
the coreceptor in cellular conjugates should favor X4 Envs.
However, we show that both X4 and R5 Envs formed sim-
ilar amounts of cellular conjugates with primary CD4 T
cells (Figure 2). Moreover, coreceptor blockade did notPage 7 of 13
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Preferential LFA-1-independent transfer of HIV particles to CD45RO+ cells during T cell-T cell synapsesFigu  5
Preferential LFA-1-independent transfer of HIV particles to CD45RO+ cells during T cell-T cell synapses. Panel A. MOLT cells chronically 
infected with NL4-3 (grey bars) and BaL (dark bars) viruses or left uninfected (white bars) were cultured with purified primary CD4 T cells. After 2 h of 
coculture, cells were stained with anti-CD45RO and anti-HIV p24 antibodies. Analysis of HIV transfer in the absence (left graph) or presence (right graph) 
of the RM3A5 blocking mAb against ICAM-1 was performed after gating separately CD45RO and CD45RA CD4 T cells. Panel B shows the expression of 
HIV Env (right) and ICAM-1 (left) in 293T transfected cells (empty peaks), solid peaks correspond to negative controls of staining. Panel C shows HIV 
transfer from 293T cells transfected with an Env defective and an NL4-3 Env plasmids, to CD45RO- (RO-) and CD45RO+ (RO+) target cells in the 
absence (light bars) or presence (grey bars) of ICAM-1 expression. HIV transmission was again measured in the absence (left graph) or the presence (right 
graph) of the blocking RM3A5 antibody against ICAM-1. Values are Mean ± SD of 3 experiments performed with CD4 T cells from 3 different donors. 
Asterisks denote significant differences in HIV transmission to the CD45RA CD4 T subset compared to CD45RO cells (Panel A and C). Significant differ-
ences intrasubsets induced by ICAM-1 expression are also indicated by asterisks in panel C, while ns denotes no statistical significance.
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The role of adhesion molecules in HIV transmission between primary CD4 T cellsFigu e 6
The role of adhesion molecules in HIV transmission between primary CD4 T cells. In panel A the expression of the indicated adhesion mole-
cules was analyzed in the surface of T cells from a representative NL4-3 infected PBMC culture. Cells were gated as CD3+/CD8-/CD4+ PBMCs (non-pro-
ductively infected cells, upper histograms) or CD3+/CD8-/CD4- PBMCs (productively infected cells, lower histograms). Histograms show a representative 
experiment displaying the expression of each individual antigen (solid peaks) with the negative control of staining (empty peaks). In panel B, purified pro-
ductively HIV infected CD3+/CD8-/CD4- PBMCs were cocultured with CMFDA-labeled primary unstimulated CD4 T cells. After 24 hours of coculture 
cells were stained with anti-CD45RO and anti-HIV CA p24 antibodies. HIV transmission was measured in both memory CD45RO+ (RO+ solid bars) and 
naive (RO-, empty bars) subsets in the presence of Leu3a, C34 and a panel of blocking agents against adhesion molecules used at the same concentrations 
as in Figure 3 (whole IgGs against ICAM-1, LFA-1 and ICAM-3, soluble ICAM-1 or Fab fragments of the anti-ICAM-3 mAb 140.11). Values are Mean ± SD 
of data corresponding to up to 6 different donors. Asterisks indicate significant differences (p < 0.05) from control or between divalent and monomeric 
blocking agents.
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blockade. Thus, the implication of coreceptors in HIV
transmission is subsequent to the cellular contact and
determine further cell-to-cell fusion, productive infection
or death of target cells [23].
The potential role of adhesion molecules (mainly LFA-1
and ICAM-1) is unexpectedly secondary for HIV transfer
from MOLT cells or primary infected T cells to CD4 T cells.
We have observed that Env-independent contacts between
uninfected MOLT cells and CD4 T cells are near back-
ground levels (Figure 2) and that the blockade of adhe-
sion molecules, employing inhibitory specific mAbs, did
not significantly modify HIV Env-mediated cellular con-
tacts or HIV transfer (Figure 2, 3). Noteworthy, all anti-
bodies were titrated and added at saturating
concentrations in inhibitory experiments. As a positive
control, activity was assessed in parallel experiments in
which LFA-1 and ICAM-1 antibodies efficiently blocked
monocyte aggregation induced by IL-12 and IL-18 (data
not shown, G Coma, unpublished results) [24]. Moreo-
ver, the anti-ICAM-1 mAb RM3A5 inhibited the modest
effect (2-fold increase in HIV transfer to memory cells)
observed when ICAM-1 is expressed in 293 T cells (Figure
5C).
The secondary role of ICAM-1 in HIV transfer between
CD4 T cells and its limited effect in 293T cells is contradic-
tory with the more relevant role reported in the infection
of CD4 T cells by free HIV particles [13], and the complete
requirement of this molecule for transinfection induced
by DC [9]. Of note, T cell-T cell contacts and DC-T cell
contacts are relatively different processes. We have also
worked with DC, and we have found that, in contrast to T
cell-T cell contacts, high level of DC-T cell contacts are
observed in the absence of HIV Env (IP, NIU unpublished
results) [9]. In fact, for DC mediated transinfection of
CD4 T cells, HIV takes advantage of naturally occurring
cellular contacts during DC scanning of T cells or antigen
presentation. In contrast, for efficient transmission
between T cells, HIV forces the contacts through Env
expression on the surface of infected cells, as T cell-T cell
contacts are low in the absence of HIV Env. In this regard,
Env expression has been recently reported to increase the
number of effective contacts between infected DC and T
cells [25] despite the relevant role of adhesion molecules
in this type of synapses [26,27]. It is therefore reasonable
that Env plays a key role in the formation of conjugates
between CD4 T cells that in vitro have shown low levels of
Env-independent contacts. In vivo, adhesion molecules
may also actively participate in antigen-dependent mech-
anisms of HIV spread between CD4 T cells, involving reg-
ulatory mechanisms or antigen presentation. However,
the contribution of T cell contacts to regulatory mecha-
nisms is unclear [28], and antigen presentation is
impaired by Nef-induced down regulation of MHC Class
II molecules and the fast kinetics of Env expression in
infected cells [29,30].
The contribution of adhesion molecules to HIV spread
has been widely studied. Early reports suggest a role in
syncytium formation but not in HIV spread or replication
[31,32]. Also efficient Env functions, such as cell-to-cell
fusion or HIV transfer, have been reported in LFA-1-defi-
cient cells or expressing low affinity forms of this integrin
[8,31]. A more recent report focused on the formation of
virological synapses suggests that cellular conjugates and
cell-to-cell HIV transmission were poorly affected by the
blockade of adhesion molecules, and that only morpho-
logical determinants of virological synapses appear to be
inhibited [8]. Our results fully agree with a secondary role
for adhesion molecules in the formation of cellular conju-
gates and the transfer of HIV particles between infected
and uninfected T cells, and demonstrate that the binding
of Env to CD4 governs the formation of cellular conju-
gates. Interestingly, signaling through LFA-1 and ICAM-3
appear to modulate the extent and the selectivity of HIV
transfer between primary CD4 T cells, an effect that may
be relevant for HIV spread in vivo.
Our data point to a different role of ICAM-1 in HIV trans-
fer from MOLT or 293T cells to CD4 T cells. One can spec-
ulate that cellular contacts and virus transmission are
regulated by a balance between the expression of Env and
adhesion molecules on effector cells. When HIV is pre-
sented by 293T cells we detected additive contributions of
both Env and ICAM-1 to HIV transfer, most likely due to
the higher expression of ICAM-1, which may increase the
number or cellular contacts or alternatively may signal
through LFA-1 in target cells. In contrast, during HIV pres-
entation by infected CD4 T cells (primary or MOLT cells),
this equilibrium is completely unbalanced towards a full
control of HIV transmission by Env binding to CD4.
By analogy to cell-free HIV attachment, which preferen-
tially targets memory CD4 T cells [14,33], we have also
analyzed the selectivity of cell-to-cell HIV transfer for CD4
T cell subsets. Unexpectedly, MOLT, 293T and primary
infected cells targeted CD45RO+ CD4 T cells by a mecha-
nism independent of LFA-1 (Figures 5 and 6). A potential
explanation could be associated with the organization of
signaling molecules, including ZAP70, which is more effi-
ciently recruited to the immunological synapse in mem-
ory cells [34]. Interestingly, ZAP70 signaling has been also
involved in the formation of virological synapses and cell-
to-cell HIV spread [35].
Conclusion
The transfer of HIV particles between infected and unin-
fected CD4 T cells is governed by HIV Env binding to CD4Page 10 of 13
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LFA-1 and ICAM-1 or -3 are not strictly required for HIV
transfer but their signaling capacity modulates the extent
and selectivity of HIV transfer.
Materials and Methods
Cells
Peripheral blood cells from healthy blood donors were
provided by the Banc de Sang i de Teixits (BST) and
obtained after approval from the Ethical Committee of
the Center. Peripheral blood mononuclear cells (PBMC)
were obtained from a standard Ficoll density gradient
purification. Mononuclear cells were immediately used
for further purification of T cell subsets. Whole CD4 T
cells, memory CD4 T cells (CD45RO+) and naïve CD4 T
cells (CD45RA+) were purified by negative immunomag-
netic selection using the appropriate cocktails of antibod-
ies (Miltenyi Biotec SL, Madrid, Spain). Purity of isolated
populations (> 95%) was assessed by flow cytometry after
CD4, CD45RO and CD45RA staining (BD Biosciences).
Primary cells were cultured in RPMI1640 medium supple-
mented with 10% heat inactivated fetal calf serum (FCS,
Invitrogen, Barcelona, Spain) in the absence of any other
stimuli.
The T-lymphoblastoid MOLT cell lines chronically
infected with X4 or R5-tropic HIV-1 have been previously
described [18,23]. Envelopes used were NL4-3 and BaL as
prototypic X4 and R5 HIV isolates, respectively. HEK 293T
cells (obtained from the NIH AIDS Reagent Program)
were cultured in DMEM. All media were supplemented
with 10% heat inactivated FCS and selection antibiotics
when required.
Antibodies and determination of cell-surface expression
The expression of the adhesion molecules was studied
using the following antibodies: anti-CD11 (LFA-1 α
chain, mAb HI111, Ebioscience, San Diego, USA), anti-
CD18/LFA-1 β chain mAb 68.5A5 [36] anti-LFA-1 active
form mAb24 (Abcam, Oxford UK) [37], anti-CD54/
ICAM-1 RM3A5 (kindly provided by Dr. R. Vilella, Hospi-
tal Clínic, Barcelona, Spain) [38,39], anti-ICAM-2 mAb
CBR-IC2/2 (Axxora, Switzerland), anti-CD50/ICAM-3
140.11 (kindly provided by Dr. R. Vilella, Hospital Clínic,
Barcelona, Spain) [40], anti-CD29 mAb P4C10 (Chemi-
con, Hamphsire UK) and anti-CD147 mAb HIM6 (BD,
Madrid Spain). Cells were incubated for 20 min, washed
with PBS and incubated with FITC-labeled goat anti-
mouse (BD Bioscience, Madrid, Spain). The FITC-labeled
goat anti-mouse was used as negative control. Cells were
finally washed twice again with PBS and fixed with for-
maldehyde 1% before flow cytometry analysis. Expression
was determined in effector MOLT cells (uninfected or
HIV-1-infected), 293T cells and PBMCs (uninfected or
HIV-1-infected) and in target CD4 T cells. After titration
by flow cytometry, the above-described antibodies were
used at saturating concentrations in coculture of effector
cells with primary CD4 T cells to evaluate their effect on
HIV transfer. Expression of CD4 was determined using the
anti-CD4 mAb Leu3a (BD Bioscience, Madrid, Spain). The
expression of HIV Env was determined by using a pool of
serums from HIV infected patients (dilution 1/10), after
washing unbound antibodies, Env expression was
revealed using a FICT-coupled goat anti-human antibody
(Dako Cytomation, Barcelona, Spain). For quantitative
evaluation of cell surface expression, Relative Fluores-
cence Intensity values were calculated by dividing the
Mean Fluorescence Intensity of positive and negative con-
trols of staining.
In some experiments sICAM-1 (R&D Systems, Minneapo-
lis, MN) and Fab fragments of ICAM-3 mAb 140.11 were
also used. Fab 140.11 was obtained by digestion of 10 mg
of whole IgG using a papain-based commercial kit (Fab
Preparation Kit, Thermo Scientific, Barcelona, Spain) fol-
lowing manufacturer's instructions. After digestion, Fab
was purified using a Protein A column that yielded 90%
pure Fab preparations, as assessed by SDS-PAGE. Main
contaminant were Fc fragments, without detectable IgG.
Measuring cellular conjugates
To analyze the contacts established between uninfected or
infected MOLT cells and primary target cells, purified CD4
T cells were first labeled with the cell tracker CMRA
(Molecular Probes, Leiden, NL) during 30 minutes,
washed twice with PBS and left overnight at 37°C. Then,
stained cells were cocultured with MOLT cells (200,000
cells of each type) for 2 hours at 37° with or without shak-
ing conditions on a 96 well flat-bottom plate. Inhibitors
tested were: the anti-CD4 mAb Leu3a (BD Biosciences, 1
μg/ml), the gp41 inhibitor C34 (Service of Peptide Syn-
thesis, University of Barcelona, 1 μg/ml), the CXCR4
antagonist AMD3100 and the CCR5 antagonist TAK779
(both obtained through the NIH AIDS Reagent Program
and used at 10 μg/ml). The following mAbs R7.1 (LFA1),
mab24 (activated LFA-1) RM3A5 (ICAM-1) and 140.11
(ICAM-3) were used at 10 μg/ml. Following the incuba-
tion time, 50 μL/well of formaldehyde 5% in PBS were
added to the cultures without perturbing cellular conju-
gates, which were analyzed 15 minutes later in a LSRII
flow cytometer equipped with a plate loader (BD Bio-
science, Madrid, Spain). All the events with similar mor-
phology to MOLT cells and at the same time being
positive for the cell tracker label (CMRA) were considered
to be stable cellular conjugates between an effector MOLT
cell and a target primary CD4 T cell. Percentage of cellular
contacts was calculated as follows: {conjugates/(conju-
gates +CD4 free cells)}x100.Page 11 of 13
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HIV transfer from infected to uninfected cells was assessed
after coculturing 200,000 target primary CD4 T cells with
200,000 effector infected MOLT/CCR5 cells in a final vol-
ume of 200 μl. Uninfected MOLT/CCR5 cells were used as
control. All assays were performed in 96-well plates using
RPMI1640 medium supplemented with 10% FCS. After 2
or 24 hours of culture at 37°C, cells were washed with PBS
containing 1% FCS. Cells were fixed, permeabilized (Fix &
Perm, Caltag, Burlingame, CA) and stained with PE-
labeled KC57 anti-HIV-p24 antigen (p24) mAb (Coulter,
Barcelona, Spain). Labeled cells were washed, resus-
pended in formaldehyde 1% with PBS and analyzed by
flow cytometry as described [18]. In some experiments,
cells were surface stained with APC-labeled anti-CD45RO
antibodies prior to fixation. HIV transfer was independ-
ently analyzed after gating CD45RO+ cells (memory) and
CD45RO- cells (naïve). Inhibitors were used at the con-
centrations described above.
Transfections
Subconfluent 293T cells seeded in a 6-well plate were co-
transfected with 4 μg of HIV-1 NL4-3 expression plasmid
lacking a functional Env (pNL4-3.Luc.R-E-; NIH AIDS
Reagent Program) together with an Env (gp160) expres-
sion plasmid pCDNA3-NL4-3 at a ratio 1:2 using a Cal-
phos transfection system (Clontech), adding or not an
ICAM-1 expression vector to the transfection (pCDNA3-
ICAM-1).
Twenty-four hours post-transfection, 293T cells were coc-
ultured with CD4 primary T cells for 24 h at a ratio 2:1 in
the presence or the absence of the inhibitors described
above. The level of p24 antigen expression was assessed as
described above and was analyzed in 293T cells and CD4
T cells (identified by forward and side scatter values) to
determine the efficiency of transfection and the percent-
age of transmission, respectively. ICAM-1 expression in
293T cells was evaluated as described above using the
RM3A5 mAb.
Isolation of productively HIV infected primary cells
PBMCs from healthy donors were cultured for 72 hours in
the presence of 6 U/mL IL-2 (Roche Diagnostics, Spain)
and 4 μg/mL phytohemagglutinin (PHA, Sigma-Aldrich,
Spain). PBMCs were infected with an X4 virus (multiplic-
ity of infection = 1) during 4 hours, washed twice with
PBS and left with RPMI1640 medium supplemented with
10% heat inactivated fetal calf serum containing IL-2 (10
U/mL). In the following days, the expression of p24 anti-
gen, CD3, CD4, and CD8 was monitored by flow cytom-
etry as described [18]. Only CD3+/CD8-/CD4-/p24+ cells
were considered to be productively infected because of the
complete disappearance of CD4 from the surface of HIV-
infected cells. These cells were purified when its percent-
age reached 3% or above. A combination of cocktail of
antibodies used to purify CD4 and CD8 T cells by negative
selection (Miltenyi Biotec SL, Madrid, Spain) was used at
a ratio 1:1 in order to obtain the desired eluted fraction
(CD4-CD8-). Purity of the isolated population was
assessed by flow cytometry after CD4 and p24 staining
and compared to the retained fraction (CD4+ CD8+).
Enriched infected cells were usually > 50% p24 bright.
In order to measure HIV transfer to uninfected CD4 T
cells, target cells were labeled with the CMFDA cell tracker
(Molecular Probes, Leiden, NL) as described above for
CMRA. Cocultures of 300,000 effector CD4-p24+ PBMCs
with 150,000 target CD4 T cells were incubated for 24
hours at 37°C 5% CO2, and intracellular p24 was meas-
ured and analyzed as described above.
Statistics
Statistic analysis was performed using two-sided Student's
t test. P values < 0.05 were considered to indicate statisti-
cal significance.
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